文献速递脑血管病外科神经重症

恶性大脑中动脉梗死去骨瓣减压术的适应证、时机与结局:瑞典多中心研究

Indications, Timing, and Outcome of Decompressive Craniectomy in Malignant Middle Cerebral Artery Infarction: A Swedish Multicenter Study.
PubMed 文献 · World Neurosurg · 2025-12-26

该回顾性多中心队列研究纳入2008至2022年瑞典4个神经外科中心治疗的335例恶性大脑中动脉梗死行去骨瓣减压术患者,评估适应证、手术时机与6个月结局。结果显示中位年龄55岁,去骨瓣减压中位时间38小时,6个月中位mRS为4,死亡率17%,仅19%和12%患者符合DESTINY I和II试验标准。各中心手术实践与随机对照试验标准存在差异,但结局无显著差异。

要点

  • 真实世界中去骨瓣减压的适应证和时机与DESTINY试验标准存在明显差异。
  • 尽管各中心实践不同,6个月结局无显著差异。
  • 仅少数患者符合 landmark 随机对照试验的纳入标准。

核心结论

  • 恶性大脑中动脉梗死去骨瓣减压的适应证和时机在各中心间及与随机对照试验标准间存在明显差异,但结局无显著差异。

研究设计与样本

  • 回顾性瑞典多中心队列研究,纳入4个神经外科中心2008至2022年335例接受去骨瓣减压的恶性大脑中动脉梗死患者。

主要发现

  • 中位年龄55岁(48-61),75%为男性。
  • 去骨瓣减压前中位GCS运动评分5分(5-6),Charlson合并症指数3分(3-4)。
  • 去骨瓣减压中位时间为卒中发作后38小时(25-56)。
  • 6个月中位mRS为4分(4-5),24%患者mRS≤3,死亡率为17%。
  • 仅19%和12%患者分别符合DESTINY I和II试验标准。

临床怎么用

  • 真实世界中去骨瓣减压的适应证和时机可不同于随机对照试验严格标准,各中心结局无显著差异。

局限性

  • 回顾性研究设计,未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Malignant middle cerebral artery infarction (MMI) can cause life-threatening edema with high mortality rates. Randomized controlled trials (RCTs) have shown that decompressive hemicraniectomy (DC) can improve survival rate and functional outcome in selected MMI patients. However, real-world outcomes are less well described. OBJECTIVE: To investigate DC indications, timing, and outcomes in MMI patients treated at 4 Swedish neurosurgical centers and the degree of alignment of real-world patient selection with eligibility criteria from 2 landmark RCTs-DESTINY I & II. METHODS: This retrospective, Swedish multicenter (n = 4) cohort study included 335 MMI patients treated with DC between 2008 and 2022. Demographics, clinical and radiological status, surgical factors, and 6-month outcomes (modified Rankin Scale [mRS]) were collected and compared across centers and with DESTINY trials. RESULTS: Median age was 55 (48-61) years, and 75% were male. Pre-DC, median Glasgow Coma Scale Motor score was 5 (5-6) and Charlson Comorbidity Index score was 3 (3-4). DC was performed at a median of 38 (25-56) hours from stroke onset. Median mRS at 6 months was 4 (4-5), 24% had mRS ≤ 3, and mortality was 17%. Only 19% and 12% of patients would have qualified for DESTINY I and II trials, respectively. CONCLUSIONS: Indication and timing of DC as a treatment of MMI demonstrated notable discrepancies in surgical practice across centers and compared to landmark RCTs. However, despite differences in timing and indications for DC, the outcome did not differ significantly across centers. Our findings provide insight into the outcome of DC performed for MMI outside the strict criteria supported by level 1 evidence.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Alhamdan M, Corell A, Holmgren K, et al. Indications, Timing, and Outcome of Decompressive Craniectomy in Malignant Middle Cerebral Artery Infarction: A Swedish Multicenter Study. World Neurosurg. 2025. PMID: 41456756. doi:10.1016/j.wneu.2025.124761

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。